Pablo Berlanga

Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)

Andrea Ferrari, Max M. van Noesel, Bernadette Brennan et al. · The Lancet Child & Adolescent Health · 2021 · 52 citations

Prospective Nrsts 2005, Surgical Pathology, Pediatrics +2

miR‐200c and phospho‐AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis

Pablo Berlanga, Lisandra Muñoz, Marta Piqueras et al. · Molecular Oncology · 2016 · 49 citations · Full text

Methanesulfonyl Fluoride (MSF): A Double-Blind, Placebo-Controlled Study of Safety and Efficacy in the Treatment of Senile Dementia of the Alzheimer Type

Donald E. Moss, Pablo Berlanga, Miriam Hagan et al. · Alzheimer Disease & Associated Disorders · 1999 · 45 citations

Alzheimer Type, Alzheimer's Disease, Neurology +17

Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition

Elena Sanmartín, Lisandra Muñoz, Marta Piqueras et al. · Clinical Cancer Research · 2017 · 42 citations

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial

Raphael J. Morscher, Caroline Brard, Pablo Berlanga et al. · European Journal of Cancer · 2021 · 36 citations · Full text

Oncology, Pharmacology, Clinical Trials +10